Skip to content
  • Saturday, 15 August 2026
  • 1:10 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Takara Bio Unveils Benchmarking Study Comparing Trekker FX with Visium HD and Xenium 5K for Spatial Transcriptomics in FFPE Tissues
Biotech & Genetic Research

Takara Bio Unveils Benchmarking Study Comparing Trekker FX with Visium HD and Xenium 5K for Spatial Transcriptomics in FFPE Tissues

Jia Lissa Jun 17, 2026 0

In a significant development for the field of spatial transcriptomics, Takara Bio has announced a comprehensive benchmarking study designed to…

Read More
Biotech & Genetic Research

Delivering true single-cell spatial omics using Trekker® technology

Jia Lissa May 7, 2026 0

The scientific community is abuzz with the potential of a groundbreaking advancement in cellular analysis, as Takara Bio introduces its…

Read More
The Paradox of Rest How Immersive Dreams Function as Guardians of Perceived Sleep Depth and Mental RestorationBeyond InheritanceAstrocytes Redefine the Neurobiology of Fear: New Research Challenges the Neuron-Centric View of Emotional MemoryControlling diabetes without insulin injections thanks to new implant
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ